TNFRSF4 and neoplasm: We found that treatment with PL1-OX40 + anti-OX40 Ab significantly reduced tumor growth compared with OX40 mRNA + anti-OX40 Ab or PL1-OX40 (nocap) + anti-OX40 Ab controls (Supplementary Fig. 10a–c).